Infant Phototherapy Devices Market, Configuration, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580542
  • Report
  • Region: Global
  • 155 pages
  • Allied Analytics LLP
1 of 4
The global infant phototherapy devices market was valued at $71,730 thousand in 2016, and is expected to reach $103,745 thousand by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Phototherapy refers to the use of light for the treatment of jaundice in infants. It is one of the most common methods used to reduce the bilirubin (the compound that leads to jaundice) levels in infants. During phototherapy, an infant lies in a plastic crib, and is exposed to a type of light that is absorbed by its skin. During this process, the bilirubin in the baby's body is converted into a much simpler water-soluble form, which can be easily excreted through stool and urine.

The growth of the global infant phototherapy devices market is driven by rise in prevalence of neonatal jaundice, effectiveness of phototherapy over other treatment methods, and technological advancements in the field of infant phototherapy. However, side effects of phototherapy treatment are expected to impede the market growth. Conversely, huge market potential in the developing regions is expected to offer opportunities for market growth during the forecast period.

The report segments the market based on light source, configuration, end user, and region. On the basis of light source, the market is classified into fluorescent lamps, light-emitting diodes (LEDs), quartz halogen lamps, and gas discharge tubes. By configuration, it is bifurcated into mobile device and fixed device. Depending on end user, it is fragmented into hospitals and neonatal clinics. Regionally, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Analysis by light source helps to understand the various types of light sources used in infant phototherapy devices.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Light Source

Fluorescent Lamps (FL)
Light-emitting Diodes (LEDs)
Quartz Halogen Lamps
Gas Discharge Tubes

By Configuration

Mobile Device
Fixed Device

By End User

Hospital
Neonatal Clinics

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Atom Medical Corporation
AVI Healthcare Pvt. Ltd.
D-Rev
General Electric Company
Ibis Medical Equipment & Systems Pvt. Ltd.
Natus Medical Incorporated
Ningbo David Medical Device Co., LTD.
Novos Medical Devices San. Tic. Imp. and Ihr. Ltd. Sti.
Weyer GmbH
Zhengzhou Dison Instrument and Meter Co., Ltd.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

Istanbul Medikal Ltd. Sti.
Elektro-mag
Ardo medical AG
S S Technomed Pvt. Ltd.
TSE SPOL. S. R. O.
Okuman Medikal Sistemler Ltd.
Alfamedic S.R.O.
Phoenix Medical Systems (P) Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Market share analysis, 2016
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Rise in prevalence of neonatal jaundice
3.3.1.2. Effectiveness of phototherapy over other treatment methods
3.3.1.3. Technological advancements in phototherapy devices
3.3.2. Restraints
3.3.2.1. Side effects of phototherapy treatment
3.3.3. Opportunity
3.3.3.1. Huge market potential in the developing regions
3.3.4. Impact Analysis

CHAPTER 4: INFANT PHOTOTHERAPY DEVICES MARKET, BY LIGHT SOURCE
4.1. Overview
4.1.1. Market size and forecast
4.2. LEDs
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Fluorescent lamps
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Gas discharge tubes
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Quartz halogen lamps
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

CHAPTER 5: INFANT PHOTOTHERAPY DEVICES MARKET, BY CONFIGURATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Mobile device
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Fixed device
5.3.1. Market size and forecast
5.3.2. Market analysis, by country

CHAPTER 6: INFANT PHOTOTHERAPY DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Neonatal clinics
6.3.1. Market size and forecast
6.3.2. Market analysis, by country

CHAPTER 7: INFANT PHOTOTHERAPY DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. infant phototherapy devices market, by light source
7.2.2.1.2. U.S. infant phototherapy devices market, by configuration
7.2.2.1.3. U.S. infant phototherapy devices market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada infant phototherapy devices market, by light source
7.2.2.2.2. Canada infant phototherapy devices market, by configuration
7.2.2.2.3. Canada infant phototherapy devices market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico infant phototherapy devices market, by light source
7.2.2.3.2. Mexico infant phototherapy devices market, by configuration
7.2.2.3.3. Mexico infant phototherapy devices market, by end user
7.2.3. North America infant phototherapy devices market, by light source
7.2.4. North America infant phototherapy devices market, by configuration
7.2.5. North America infant phototherapy devices market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany infant phototherapy devices market, by light source
7.3.2.1.2. Germany infant phototherapy devices market, by configuration
7.3.2.1.3. Germany infant phototherapy devices market, by end user
7.3.2.2. France
7.3.2.2.1. France infant phototherapy devices market, by light source
7.3.2.2.2. France infant phototherapy devices market, by configuration
7.3.2.2.3. France infant phototherapy devices market, by end user
7.3.2.3. UK
7.3.2.3.1. UK infant phototherapy devices market, by light source
7.3.2.3.2. UK infant phototherapy devices market, by configuration
7.3.2.3.3. UK infant phototherapy devices market, by end user
7.3.2.4. ITALY
7.3.2.4.1. Italy infant phototherapy devices market, by light source
7.3.2.4.2. Italy infant phototherapy devices market, by configuration
7.3.2.4.3. Italy infant phototherapy devices market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain infant phototherapy devices market, by light source
7.3.2.5.2. Spain infant phototherapy devices market, by configuration
7.3.2.5.3. Spain infant phototherapy devices market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe infant phototherapy devices market, by light source
7.3.2.6.2. Rest of Europe infant phototherapy devices market, by configuration
7.3.2.6.3. Rest of Europe infant phototherapy devices market, by end user
7.3.3. Europe infant phototherapy devices market, by light source
7.3.4. Europe infant phototherapy devices market, by configuration
7.3.5. Europe infant phototherapy devices market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan infant phototherapy devices market, by light source
7.4.2.1.2. Japan infant phototherapy devices market, by configuration
7.4.2.1.3. Japan infant phototherapy devices market, by end user
7.4.2.2. China
7.4.2.2.1. China infant phototherapy devices market, by light source
7.4.2.2.2. China infant phototherapy devices market, by configuration
7.4.2.2.3. China infant phototherapy devices market, by end user
7.4.2.3. India
7.4.2.3.1. India infant phototherapy devices market, by light source
7.4.2.3.2. India infant phototherapy devices market, by configuration
7.4.2.3.3. India infant phototherapy devices market, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia infant phototherapy devices market, by light source
7.4.2.4.2. Australia infant phototherapy devices market, by configuration
7.4.2.4.3. Australia infant phototherapy devices market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea infant phototherapy devices market, by light source
7.4.2.5.2. South Korea infant phototherapy devices market, by configuration
7.4.2.5.3. South Korea infant phototherapy devices market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific infant phototherapy devices market, by light source
7.4.2.6.2. Rest of Asia-Pacific infant phototherapy devices market, by configuration
7.4.2.6.3. Rest of Asia-Pacific infant phototherapy devices market, by end user
7.4.3. Asia-Pacific infant phototherapy devices market, by light source
7.4.4. Asia-Pacific infant phototherapy devices market, by configuration
7.4.5. Asia-Pacific infant phototherapy devices market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil infant phototherapy devices market, by light source
7.5.2.1.2. Brazil infant phototherapy devices market, by configuration
7.5.2.1.3. Brazil infant phototherapy devices market, by end user
7.5.2.2. South Africa
7.5.2.2.1. South Africa infant phototherapy devices market, by light source
7.5.2.2.2. South Africa infant phototherapy devices market, by configuration
7.5.2.2.3. South Africa infant phototherapy devices market, by end user
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia infant phototherapy devices market, by light source
7.5.2.3.2. Saudi Arabia infant phototherapy devices market, by configuration
7.5.2.3.3. Saudi Arabia infant phototherapy devices market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA infant phototherapy devices market, by light source
7.5.2.4.2. Rest of LAMEA infant phototherapy devices market, by configuration
7.5.2.4.3. Rest of LAMEA infant phototherapy devices market, by end user
7.5.3. LAMEA infant phototherapy devices market, by light source
7.5.4. LAMEA infant phototherapy devices market, by configuration
7.5.5. LAMEA infant phototherapy devices market, by end user

CHAPTER 8: COMPANY PROFILES
8.1. Atom Medical Corporation
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.2. AVI Healthcare Pvt. Ltd.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.3. D-Rev
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. GE Healthcare (A healthcare division Of GE Company)
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.5. Ibis Medical Equipment & Systems Pvt. Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.6. Natus Medical Incorporated
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.7. Ningbo David Medical Device Co. Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.8. Novos Medical Devices San. Tic. Imp. And Ihr. Ltd. Sti.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.9. Weyer GmbH
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.10. Zhengzhou Dison Instrument and Meter Co. Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Infant Phototherapy Devices Market, by Light Source, Configuration, and End Userlobal Opportunity Analysis and Industry Forecast, 2017-2023," the global infant phototherapy devices market was valued at $71,730 thousand in 2016, and is expected to reach $103,745 thousand by 2023, growing at a CAGR of 5.3% from 2017 to 2023.

Phototherapy is the use of light to treat neonatal jaundice. During this process, an infant's body is exposed to light for a certain period of time in controlled conditions. This light is absorbed by the neonates skin and breaks down complex bilirubin into water-soluble simple compound, which can be excreted out of the body through urine or stool.

Rise in prevalence of jaundice in infants, effectiveness of phototherapy over other treatment methods, and technological advancements in the field of infant phototherapy drive the market growth. However, side effects of phototherapy treatment are expected to restrain the market growth. Moreover, huge market potential in the developing regions is expected to offer several opportunities for market growth during the forecast period.

Based on light source, LED garnered more than four-fifths of the market share in 2016, and is expected to maintain its dominant position during the analysis period, as it has proved to be the most effective light in the breakdown of bilirubin into simpler forms.

Based on configuration, the mobile device segment held the major share (more than four-fifths) in 2016, and is expected this trend throughout the forecast period.

Key Findings of the Infant Phototherapy Devices Market

The LED segment is expected to grow with a CAGR of 5.5% from 2017 to 2023.
Mobile device is expected to grow at the highest CAGR of 5.4%.
The hospitals segment held a major share (two-thirds) in the global market in 2016, and is expected to retain it throughout the forecast period.
Asia-Pacific is expected to register the highest growth, growing at a CAGR of 6.7% during the forecast period.

North America accounted for one-third share of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to high adoption rate of technologically advanced devices, and presence of highly sophisticated healthcare infrastructure in the region.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll